ARCHIVES

Groups Accepting Need for More Collaboration, NCI Backs Away From Drastic Structural Changes

This article is from The Cancer Letter archive.

Vol. 12 No. 28 | July 11, 1986

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Professional Societies: AACR Awards Honor 8 Scientists, Clinicians

April 2, 1999

NCI Cooperative Group Clinical Trials Approved

August 27, 2010

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

November 4, 2005